Infection Surveillance Solutions Market Size, Share, Trends, Growth Outlook

Infection Surveillance Solutions Market is estimated to increase at a Compounded Annual Growth Rate of 14.6% CAGR over the forecast period from 2024 to 2030

The Infection Surveillance Solutions Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Software, Services), By Infection (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others), By End-User (Long Term Care Centers, Hospitals, Others).

An Introduction to Infection Surveillance Solutions Market in 2024

Infection surveillance solutions are comprehensive systems and protocols implemented in healthcare facilities to monitor, track, and analyze the incidence and prevalence of healthcare-associated infections (HAIs) and other infectious diseases. In 2024, infection surveillance solutions remain critical components of infection prevention and control programs, providing healthcare organizations with the data and insights necessary to detect outbreaks, identify trends, and implement targeted interventions to reduce the risk of transmission and improve patient safety. These solutions encompass a range of surveillance methods, including manual chart review, electronic health record (EHR) data analysis, laboratory-based surveillance, and automated detection algorithms. By integrating data from various sources, such as microbiology reports, patient admissions, and device utilization, infection surveillance solutions enable healthcare facilities to monitor key metrics, such as infection rates, pathogen distributions, antimicrobial resistance patterns, and compliance with infection prevention protocols. Moreover, with the adoption of real-time surveillance technologies and data analytics tools, healthcare organizations can identify potential outbreaks or clusters of infections more quickly, allowing for timely implementation of infection control measures and containment strategies. Infection surveillance solutions also support benchmarking and comparison of infection rates across different departments, units, or facilities, facilitating quality improvement initiatives and adherence to regulatory requirements and accreditation standards. By providing actionable data and insights to infection preventionists, epidemiologists, and healthcare administrators, infection surveillance solutions contribute to the reduction of HAIs, improvement of patient outcomes, and optimization of resource allocation in healthcare settings.

Market Trend: Adoption of Real-Time Monitoring and Analytics

A significant trend in the infection surveillance solutions market is the adoption of real-time monitoring and analytics. Healthcare facilities are increasingly implementing sophisticated surveillance systems that utilize advanced analytics, artificial intelligence (AI), and machine learning algorithms to detect and track infections in real time. These solutions enable early identification of outbreaks, rapid response to potential threats, and proactive infection control measures, ultimately reducing the risk of healthcare-associated infections (HAIs) and improving patient safety. With the ongoing emphasis on infection prevention and control, there is a growing demand for infection surveillance solutions that provide actionable insights, predictive analytics, and interoperability with other healthcare systems. This trend is expected to drive market growth as healthcare facilities prioritize the implementation of comprehensive infection surveillance programs to enhance patient outcomes and reduce healthcare costs.

Market Driver: Regulatory Mandates and Quality Improvement Initiatives

A key driver fueling the infection surveillance solutions market is regulatory mandates and quality improvement initiatives aimed at reducing healthcare-associated infections (HAIs) and improving patient safety. Regulatory agencies such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have established guidelines and recommendations for infection prevention and control in healthcare settings. Additionally, healthcare accreditation organizations require healthcare facilities to implement effective infection surveillance and reporting systems as part of their accreditation process. Furthermore, initiatives such as the Hospital-Acquired Condition Reduction Program in the United States incentivize hospitals to improve infection control practices and reduce the incidence of HAIs. As healthcare providers face increasing pressure to comply with regulatory requirements, meet quality benchmarks, and enhance patient safety, the demand for infection surveillance solutions is expected to rise. These solutions enable healthcare facilities to monitor infection rates, track trends, and implement targeted interventions to prevent and control infections, driving market growth and adoption of infection surveillance technologies.

Market Opportunity: Integration with Electronic Health Records (EHR) Systems

A potential opportunity in the infection surveillance solutions market lies in the integration with electronic health records (EHR) systems. Seamless integration between infection surveillance solutions and EHR systems enables healthcare facilities to leverage patient data, clinical workflows, and laboratory results for comprehensive infection monitoring and reporting. By integrating infection surveillance functionalities into EHR platforms, healthcare providers can streamline data capture, automate surveillance processes, and facilitate timely reporting of infections to regulatory agencies and public health authorities. Additionally, integration with EHR systems allows for more efficient communication and collaboration among healthcare teams, enabling coordinated efforts to prevent and control infections. Furthermore, interoperability between infection surveillance solutions and EHR systems supports data-driven decision-making, quality improvement initiatives, and evidence-based practices in infection prevention and control. By embracing integration opportunities, infection surveillance solution providers can enhance the value proposition of their offerings, improve usability for healthcare providers, and drive market penetration in the increasingly digitized healthcare landscape. Expanding into integration with EHR systems presents a strategic opportunity for stakeholders to address evolving customer needs, drive innovation, and advance infection surveillance capabilities in healthcare settings.

Infection Surveillance Solutions Market Share Analysis: Web-based Software Solutions is the fastest growing segment over the forecast period to 2030

Among the segments of the Infection Surveillance Solutions Market, Web-based Software Solutions emerge as the fastest-growing category. This accelerated growth is driven by several factors. Web-based software solutions offer flexibility, accessibility, and real-time data analytics capabilities, making them highly desirable for infection surveillance and control in healthcare settings. The shift towards web-based platforms is fueled by the increasing adoption of electronic health records (EHRs) and the need for interoperability across healthcare systems. Additionally, web-based solutions facilitate remote access to surveillance data, enabling healthcare professionals to monitor infections, track trends, and implement preventive measures more efficiently. Furthermore, the scalability and cost-effectiveness of web-based software solutions appeal to a wide range of end-users, including long-term care centers, hospitals, and other healthcare facilities, driving their rapid adoption. As healthcare institutions prioritize infection prevention and control measures, web-based software solutions emerge as a pivotal driver in propelling the growth of the Infection Surveillance Solutions Market.

Infection Surveillance Solutions Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAsolva Inc, Baxter International Inc, Becton, Dickinson and Company, bioMérieux SA, BioVigil Healthcare Systems Inc, CenTrak Inc, Cerner Corp, CKM Healthcare Inc, Clinisys Group Ltd, Deb Group Ltd, Ecolab Inc, GOJO Industries Inc, Harris Healthcare Solutions, Medexter Healthcare GmbH, Merative Inc, PeraHealth Inc, PointClickCare corp, Premier Inc, RLDatix, STANLEY Healthcare Solutions, Vecna Technologies Inc, VigiLanz Corp, Vitalacy Inc, VIZZIA Technologies LLC, Wolters Kluwer N.V.

Infection Surveillance Solutions Market Segmentation

By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Infection Surveillance Solutions Market Companies

Asolva Inc
Baxter International Inc
Becton, Dickinson and Company
bioMérieux SA
BioVigil Healthcare Systems Inc
CenTrak Inc
Cerner Corp
CKM Healthcare Inc
Clinisys Group Ltd
Deb Group Ltd
Ecolab Inc
GOJO Industries Inc
Harris Healthcare Solutions
Medexter Healthcare GmbH
Merative Inc
PeraHealth Inc
PointClickCare corp
Premier Inc
RLDatix
STANLEY Healthcare Solutions
Vecna Technologies Inc
VigiLanz Corp
Vitalacy Inc
VIZZIA Technologies LLC
Wolters Kluwer N.V.

Reasons to Buy the Infection Surveillance Solutions Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Infection Surveillance Solutions Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Infection Surveillance Solutions Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Infection Surveillance Solutions Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Infection Surveillance Solutions Market Size Outlook, $ Million, 2021 to 2030
3.2 Infection Surveillance Solutions Market Outlook by Type, $ Million, 2021 to 2030
3.3 Infection Surveillance Solutions Market Outlook by Product, $ Million, 2021 to 2030
3.4 Infection Surveillance Solutions Market Outlook by Application, $ Million, 2021 to 2030
3.5 Infection Surveillance Solutions Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Infection Surveillance Solutions Industry
4.2 Key Market Trends in Infection Surveillance Solutions Industry
4.3 Potential Opportunities in Infection Surveillance Solutions Industry
4.4 Key Challenges in Infection Surveillance Solutions Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Infection Surveillance Solutions Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Infection Surveillance Solutions Market Outlook by Segments
7.1 Infection Surveillance Solutions Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others

8 North America Infection Surveillance Solutions Market Analysis and Outlook To 2030
8.1 Introduction to North America Infection Surveillance Solutions Markets in 2024
8.2 North America Infection Surveillance Solutions Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Infection Surveillance Solutions Market size Outlook by Segments, 2021-2030
By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others

9 Europe Infection Surveillance Solutions Market Analysis and Outlook To 2030
9.1 Introduction to Europe Infection Surveillance Solutions Markets in 2024
9.2 Europe Infection Surveillance Solutions Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Infection Surveillance Solutions Market Size Outlook by Segments, 2021-2030
By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others

10 Asia Pacific Infection Surveillance Solutions Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Infection Surveillance Solutions Markets in 2024
10.2 Asia Pacific Infection Surveillance Solutions Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Infection Surveillance Solutions Market size Outlook by Segments, 2021-2030
By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others

11 South America Infection Surveillance Solutions Market Analysis and Outlook To 2030
11.1 Introduction to South America Infection Surveillance Solutions Markets in 2024
11.2 South America Infection Surveillance Solutions Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Infection Surveillance Solutions Market size Outlook by Segments, 2021-2030
By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others
12 Middle East and Africa Infection Surveillance Solutions Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Infection Surveillance Solutions Markets in 2024
12.2 Middle East and Africa Infection Surveillance Solutions Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Infection Surveillance Solutions Market size Outlook by Segments, 2021-2030
By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Asolva Inc
Baxter International Inc
Becton, Dickinson and Company
bioMérieux SA
BioVigil Healthcare Systems Inc
CenTrak Inc
Cerner Corp
CKM Healthcare Inc
Clinisys Group Ltd
Deb Group Ltd
Ecolab Inc
GOJO Industries Inc
Harris Healthcare Solutions
Medexter Healthcare GmbH
Merative Inc
PeraHealth Inc
PointClickCare corp
Premier Inc
RLDatix
STANLEY Healthcare Solutions
Vecna Technologies Inc
VigiLanz Corp
Vitalacy Inc
VIZZIA Technologies LLC
Wolters Kluwer N.V.

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Products and Services
Software
-On-premise
-Web-based
Services
By Infection
Surgical Site Infections (SSI)
Blood Stream Infections (BSI)
Urinary Tract Infections (UTI)
Others
By End-User
Long Term Care Centers
Hospitals
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)